1
EFRUZ ASİLOĞLU @ ETTABİBHUCANCER CANCER CELL ABERRANT SİGNALİNG PATHWAYS DOMİNANT SO WE HAVE TO REDUCED AND NORMAL SİGNALİNG PATHWAYS PASSİVE SO NEED TO REACİVATİON AS NORMAL ACTİON.

Ettabibhu cancer therapy twitter 4

Embed Size (px)

Citation preview

Page 1: Ettabibhu cancer therapy  twitter  4

EFRUZ ASİLOĞLU@ETTABİBHUCANCERCANCER CELL ABERRANT SİGNALİNG

PATHWAYS DOMİNANT SO WE HAVE TO REDUCED AND NORMAL SİGNALİNG

PATHWAYS PASSİVE SO NEED TO REACİVATİON AS NORMAL ACTİON.